Brain Edema

29 registered clinical trials studyying Brain Edema — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Local Ischemic Postconditioning in Acute Ischemic Stroke NCT06526429	Shanghai Jiao Tong University Affiliated Sixth People's Hospital	N/A
Recruiting	Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMB NCT06451887	Zhejiang Provincial People's Hospital	—
Unknown	Rapid Local Ischemic Postconditioning in Acute Ischemic Stroke NCT06307743	Shanghai Jiao Tong University Affiliated Sixth People's Hospital	N/A
Unknown	Non-invasive Monitoring and Serum Marker Study in Children With Cerebral Edema NCT06017635	Qilu Hospital of Shandong University	—
Recruiting	Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery NCT05622461	Children's Hospital Medical Center, Cincinnati	N/A
Unknown	Dynamic Decompressive Craniotomy NCT05051488	Rohit Khanna, MD	—
Completed	Correlation of Trans Cranial Doppler Ultrasound and CT Scan in Monitoring of Posttraumatic Brain Edema NCT04834453	Ain Shams University	—
Completed	Diabetic Ketoacidosis Diagnosis and Management NCT06327737	Akdeniz University	—
Unknown	Non-contact DCS-Speckle Multi-parameter Imaging for Neurological Diseases NCT04623307	Ting Li	—
Unknown	The Accuracy of Brain Biological Electrical Impedance Tomography Screen for Supratentorial Tumors NCT04490954	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	A Pharmacovigilance Study of Brain Oedema NCT04311359	University of Peshawar	—
Completed	Optical Nerve Sheath Changes During Head Down Laparoscopy NCT03957837	ASST Fatebenefratelli Sacco	—
Active Not Recruiting	Automatic PredICtion of Edema After Stroke NCT04057690	University Hospital Tuebingen	—
Recruiting	Haemodynamical Optimization During Brain Surgery NCT04114799	University Hospital Hradec Kralove	N/A
Completed	Effects of Intraoperative GDFT on the Postoperative Brain Edema NCT03323580	Beijing Tiantan Hospital	N/A
Terminated	Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral E NCT02864953	Remedy Pharmaceuticals, Inc.	Phase 3
Completed	Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation NCT03573999	Aristotle University Of Thessaloniki	Phase 4
Completed	Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients) NCT05070182	Aristotle University Of Thessaloniki	—
Terminated	Swiss Prospective Autologous Bone Flap Resorption Study NCT02320955	University of Zurich	—
Completed	Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI NCT02368366	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients NCT02701582	NYU Langone Health	N/A
Completed	Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After C NCT02037815	Capital Medical University	Phase 4
Completed	A Comparison Between Two Techniques for Performing Decompressive Craniectomy NCT02594137	Hospital of the Restoration, Recife	N/A
Terminated	Tolerability Study of Xerecept® in Pediatric Patients NCT01369121	Celtic Pharma Development Services	Phase 1 / Phase 2
Terminated	Furosemide vs Placebo for Brain Relaxation NCT01054404	Northwestern University	N/A
Withdrawn	XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema NCT00226668	Celtic Pharma Development Services	Phase 3
Completed	Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI NCT00409058	Children's Hospital Medical Center, Cincinnati	N/A
Completed	An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated S NCT00226655	Celtic Pharma Development Services	Phase 3
Completed	XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors NCT00088166	Celtic Pharma Development Services	Phase 3